Clinical Topics & News
Musings of an Academician on Changing Times in Hematology and Oncology
Fed Pract. 2013 October;30(10):11-12
Author(s):
Mehta P
Author and Disclosure Information
Paulette Mehta, MD, MPH
I began making house calls when I was 5 years old. That was when my father started taking me along on his house calls. He was an internist in New York City in the days when doctors still made house calls, carried doctors bags, and sat with patients to comfort them. Together, we answered phone calls from distraught patients, tracked directions to their homes on our printed maps, and drove through lonely streets to find them. Throughout my childhood and until the time I entered medical school, I was my father's apprentice.
Clinical Topics
-
FDA approves first gene therapy for hemophilia B -
Death Cafe in Hematology Oncology -
The Effect of Adjuvant Therapy Type on Survival for Patients With Sage II Osteosarcoma -
A Case Report of Palliative Pembrolizumab Monotherapy for a Poorly Differentiated Malignancy -
Chimeric Antigen Receptor T-cell Therapy in the Veterans Affairs Network: the Tennessee Valley Healthcare System Experience
Digital Edition
-
AVAHO 2021 Meeting Posters and Abstracts Publish date: September 22, 2021 -
Advances in Hematology and Oncology Publish date: September 3, 2021 -
Advances in Hematology and Oncology Publish date: May 20, 2021 -
August 2020 Advances in Precision Oncology -
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)
Multimedia
-
Experts break down latest CAR T-cell advances in lymphoma Publish date: January 22, 2020 -
SC daratumumab deemed feasible for every multiple myeloma patient Publish date: July 11, 2019 -
Researchers propose new risk groups for NK-AML Publish date: May 8, 2019
Conference Coverage
-
I am not fine: The heavy toll cancer takes Publish date: October 5, 2022 -
Blood test for multiple cancers: Many false positives Publish date: September 12, 2022 -
Patients with blood cancers underutilize palliative care Publish date: June 23, 2022 -
Novel COVID-19 vaccine could fill the void for patients with blood cancers Publish date: April 18, 2022 -
NHL: As a second-line treatment in phase 3 trial, tisa-cel disappoints Publish date: December 15, 2021 -
TKI/BiTE combo extends survival of older patients with Ph+ALL Publish date: December 15, 2021 -
Myeloid patients respond robustly to Moderna COVID vaccine Publish date: December 12, 2021 -
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferrals Publish date: December 11, 2021 -
Bleeding disorder diagnoses delayed by years in girls and women Publish date: March 9, 2021 -
CAR T-cell products shine in real-world setting, reveal new insights Publish date: February 18, 2021
Prognostic factors of bladder cancer
Question 1 of 5